PPWR Compliance for Cosmetics & Pharmaceutical Packaging: What You Must Know
PPWR Compliance for Cosmetics & Pharmaceutical Packaging: What You Must Know Before August 2026
The EU Packaging and Packaging Waste Regulation — Regulation (EU) 2025/40 — enters mandatory application on August 12, 2026, and its impact on cosmetics and pharmaceutical packaging is both significant and distinct from other sectors. These industries face a unique regulatory intersection: packaging must simultaneously comply with the PPWR's sustainability requirements while respecting the strict safety standards imposed by the EU Cosmetics Regulation (EC) No 1223/2009 and the Falsified Medicines Directive 2011/62/EU. This article explains the specific obligations, exemptions, and practical steps for cosmetics and pharmaceutical companies.
Why Cosmetics & Pharma Packaging Is Different Under PPWR
Under the PPWR, cosmetics and pharmaceutical packaging is classified as "contact-sensitive" packaging. This classification, defined in Article 7 and Annex II of the regulation, applies to any packaging that comes into direct contact with products intended for human health or bodily application. The contact-sensitive designation has three major consequences:
- Higher recycled content thresholds apply differently — From January 1, 2030, contact-sensitive plastic packaging must contain at least 30% recycled content for PET and 10% for other plastics, but only where recycled materials meet safety requirements under existing product legislation.
- Safety-first exemption for recyclability — Article 6(7) provides that recyclability requirements shall not apply where they would compromise the safety, quality, or efficacy of the packaged product. This is critical for pharmaceutical primary packaging.
- Stricter traceability requirements — Every packaging unit must bear a type, batch, or serial number from August 2026, which aligns with existing pharma serialization requirements but creates new obligations for cosmetics brands.
PPWR Requirements Applying From August 12, 2026
The following PPWR obligations apply to cosmetics and pharmaceutical packaging from the first compliance date. There is no grace period for packaging placed on the EU market after this date:
| Requirement | PPWR Article | Cosmetics Impact | Pharma Impact |
|---|---|---|---|
| Declaration of Conformity (DoC) | Article 39, Annex VIII | Required for all packaging | Required for all packaging |
| Minimisation requirements | Article 9 | Empty space ≤ 40% | Exempt if safety requires it |
| PFAS ban (food-contact only) | Article 5 | Not directly applicable | Not directly applicable |
| Heavy metals ban | Article 5(1) | Already in force (Jan 2026) | Already in force (Jan 2026) |
| Traceability (batch/serial number) | Article 11(6) | New obligation for most brands | Already standard (FMD compliance) |
| Recyclability assessment | Article 6, Annex II | Required — grade assignment | Exemption for primary packaging if safety-critical |
Cosmetics Packaging: The Contact-Sensitive Challenge
For cosmetics brands, the PPWR introduces a paradigm shift: packaging is no longer just a marketing vehicle but a formally regulated product in its own right. Every jar, tube, bottle, pump, cap, and outer carton placed on the EU market must be assessed for recyclability, carry a Declaration of Conformity, and meet minimisation criteria.
The contact-sensitive classification creates a particular tension for cosmetics packaging. The industry has long relied on multi-material constructions — metallized plastics, mixed polymer laminates, glass-plastic combinations — to achieve premium aesthetics, product stability, and shelf life. Under the PPWR recyclability grading system (Article 6, Annex II), many of these constructions risk receiving Grade D or E, which would face a market ban from January 1, 2030.
The European Commission's April 2026 updated guidance clarifies that the safety exemption in Article 6(7) is narrowly interpreted: it applies only where recyclable alternatives would genuinely compromise product stability, not simply where reformulation would be inconvenient or costly. Cosmetics brands should therefore not rely on the exemption to avoid redesigning packaging.
Pharmaceutical Packaging: Navigating the Article 6 Exemption
Pharmaceutical packaging benefits from a broader safety exemption under the PPWR, but the scope is carefully delineated:
- Primary (immediate) packaging — Blister packs, vials, ampoules, syringes, and other packaging in direct contact with the medicinal product may be exempted from recyclability and recycled content requirements where compliance would compromise the safety, quality, or efficacy of the medicine (Article 6(7)).
- Secondary packaging — Outer cartons, leaflet inserts, and grouped packaging receive no exemption. They must fully comply with recyclability assessment, minimisation, DoC, and all August 2026 requirements.
- Tertiary/transport packaging — Shipping cases and pallets must also comply, though the April 2026 guidance confirmed that wooden pallets in active import/export use are exempt from reuse requirements.
Importantly, pharmaceutical companies must document the justification for any exemption claimed under Article 6(7). The exemption is not automatic — it requires a reasoned assessment demonstrating that no recyclable alternative exists that would maintain product integrity. This documentation must be included in the technical file alongside the Declaration of Conformity.
Recycled Content Targets: The 2030 Horizon
While recycled content minimums do not apply until January 1, 2030, cosmetics and pharmaceutical companies should begin planning now. The targets for contact-sensitive plastic packaging are:
| Material | Jan 1, 2030 | Jan 1, 2035 | Jan 1, 2040 |
|---|---|---|---|
| PET (contact-sensitive) | 30% | 50% | 50% |
| Other plastics (contact-sensitive) | 10% | — | 50% |
| PET (non-contact) | 35% | 65% | 65% |
| Other plastics (non-contact) | 10% | — | 50% |
For cosmetics, meeting these targets requires sourcing food-grade or cosmetic-grade recycled polymers — a supply chain that is still maturing. EFSA-approved recycled PET processes exist, but recycled HDPE, PP, and other polymers suitable for contact-sensitive applications remain limited. Companies should engage with recycled resin suppliers early to secure reliable supply chains before the 2030 deadline.
For pharmaceuticals, the recycled content exemption under Article 7(5) applies where the use of recycled material would compromise medicinal product safety. However, this exemption is again limited to primary packaging — secondary cartons must meet the full recycled content targets.
Digital Product Passport: August 28, 2027
From August 28, 2027, all packaging — including cosmetics and pharmaceutical packaging — must carry a Digital Product Passport (DPP) accessible via a data carrier (typically a QR code). For cosmetics brands, this means adding a DPP QR code alongside existing regulatory markings (ingredient lists, PAO symbols, batch codes). Given the typically small surface area of cosmetic packaging, the PPWR allows the DPP data carrier to be placed on the grouped or transport packaging where direct application is impractical (Article 12(4)).
For pharmaceutical companies, the DPP must coexist with the existing 2D Data Matrix required under the Falsified Medicines Directive (FMD). The European Commission has clarified that a single data carrier may serve both purposes if it meets both the FMD and PPWR technical requirements, but companies should verify this with their serialization solution providers.
Practical Compliance Roadmap
With less than four months until the August 12, 2026 deadline, cosmetics and pharmaceutical companies should prioritize the following actions:
- Audit your packaging portfolio — Identify all packaging types (primary, secondary, tertiary), materials, and constructions. Flag multi-material packaging at risk of Grade D or E recyclability ratings.
- Prepare Declarations of Conformity — Every packaging unit placed on the EU market from August 12, 2026 needs a DoC. Start drafting now using the Annex VIII template.
- Document any safety exemptions — If claiming Article 6(7) exemptions for primary pharmaceutical packaging, prepare written justifications with supporting evidence.
- Assess recyclability — Run your packaging through a recyclability assessment per Annex II. Identify which items fall below Grade C and develop redesign plans.
- Engage suppliers — Request PPWR compliance data from packaging suppliers. Ensure your converter or manufacturer can provide the information needed for your DoC.
- Plan for DPP — Begin scoping your Digital Product Passport implementation for the August 2027 deadline. Select a DPP solution provider and plan label redesigns.
How PPWR Connect Helps Cosmetics & Pharma Companies
Managing PPWR compliance across potentially thousands of packaging SKUs — each with different materials, constructions, and regulatory classifications — is a significant challenge. PPWR Connect is purpose-built to simplify this process. The platform enables you to classify packaging as contact-sensitive and track sector-specific obligations, generate Declarations of Conformity using pre-filled templates aligned with Annex VIII, assess recyclability grades and identify packaging at risk of Grade D/E bans, document Article 6(7) exemptions with structured justification workflows, prepare for recycled content reporting ahead of the 2030 deadline, and plan your Digital Product Passport rollout with integrated QR code management. Whether you manage 50 SKUs or 5,000, PPWR Connect gives you a single platform to track, document, and prove compliance. Start your assessment today.
El 12 de agosto de 2026 está más cerca de lo que piensas
Únete a 200+ empresas que se están preparando para el cumplimiento del Reglamento (UE) 2025/40 con PPWR Connect. Comienza gratuitamente durante la beta — gestiona tu Declaración de Conformidad, grados de reciclabilidad y obligaciones EPR antes del plazo.
No se requiere tarjeta de crédito. Acceso anticipado a todas las funciones de cumplimiento.